Table 2.

Correlation between clinicopathological features and expression of miR-34a-5p and LEF1 in patients with ESCC

Characteristics	n	miR-34a-5p relative expression (mean±SD)	P-value	LEF1 mRNA relative expression (mean±SD)	P-value
Clinicopathological features			<0.01**		<0.01**
Adjacent tissue	16	1		1
ESCC tissue	16	0.75 ± 0.30		2.07 ± 0.76
Age (years)			0.47		0.85
≥60	11	0.71 ± 0.10		2.10 ± 0.27
<60	5	0.83 ± 0.09		2.01 ± 0.14
Gender			0.62		0.99
Female	4	0.82 ± 0.12		2.08 ± 0.16
Male	12	0.73 ± 0.09		2.07 ± 0.25
Pathological T stage			0.01*		<0.01**
T1+T2	9	0.91 ± 0.09		1.58 ± 0.12
T3+T4	7	0.55 ± 0.07		2.70 ± 0.26
Pathological N stage			0.03*		0.02*
N0+N1	6	0.95± 0.13		1.54 ± 0.18
N2+N3	10	0.63 ± 0.07		2.39 ± 0.23
Differentiation			<0.01**		0.03*
G1	7	1.01 ± 0.08		1.62 ± 0.19
G2+G3	9	0.55 ± 0.06		2.42 ± 0.25

*P < 0.05, **P < 0.01.